Skip to main content

Table 2 Frequency of different AEs in the study population

From: Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

AEs

Frequency of occurrence

Percent of all AEs

Stomach Pain/Upset

16

22.86

GI Upset

11

15.71

Nausea

5

7.14

Reflux

5

7.14

Heartburn

4

5.71

Bloating

3

4.29

Constipation

3

4.29

Trouble with Apo-Alendronate

3

4.29

Chest Pain

2

2.86

Diarrhea

2

2.86

Loss of Appetite

2

2.86

Rectal Bleeding

2

2.86

Generally Unwell

2

2.86

Stomach Ulcer

1

1.43

Anemia

1

1.43

Rash

1

1.43

Perforated Diverticulum

1

1.43

Shortness of Breath

1

1.43

Bone Pain

1

1.43

Bowel Problems

1

1.43

Arthralgias

1

1.43

Flank Pain

1

1.43

Leg Cramping

1

1.43

Total

70

100.00

  1. AE: adverse event; GI: gastrointestinal